Nyrada: Ledger

Stories naming Nyrada. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Nyrada is not recorded as having acquired anything.

Name	Role	Sources
James Bonnar	Managing Director and Chief Executive Officer	Dealroom

Unnamed stage $8.6m

Nyrada raises $8.6M placement to fund Xolatryp heart trial

Australian biotech Nyrada has banked US$7.76 million through a share placement managed by Bell Potter, with proceeds going to its clinical pipeline, including the Phase IIa trial of Xolatryp in heart attack patients.

Dealroom Mon 21 Sep 2026 Nyrada Bell Potter James Bonnar

Nyrada

Funding history

Investors

What Nyrada bought

People

Coverage

Nyrada raises $8.6M placement to fund Xolatryp heart trial